首页> 外文期刊>Journal of chromatography, B. Analytical technologies in the biomedical and life sciences >Simultaneous determination of various aromatic amines and metabolites of aromatic nitro compounds in urine for low level exposure using gas chromatography-mass spectrometry
【24h】

Simultaneous determination of various aromatic amines and metabolites of aromatic nitro compounds in urine for low level exposure using gas chromatography-mass spectrometry

机译:气相色谱-质谱法同时测定尿液中低浓度暴露的各种芳香胺和芳香族硝基化合物的代谢物

获取原文
获取原文并翻译 | 示例
           

摘要

A newly developed method permits the simultaneous quantitative determination of various aromatic amines (or metabolites of aromatic nitro compounds, respectively) in human urine in one analytical run. Applying this method it is possible to determine aniline, toluidines, 4-isopropylaniline, o-anisidine, 3- and 4-chloroaniline, 4-bromoaniline, aminonitrotoluenes, aminodinitrotoluenes, 3,5- and 3,4-dichloroaniline, α- and β-naphtylamine and 4-aminodiphenyl. After separation from the urinary matrix by a simple liquid-liquid extraction at pH 6.2-6.4 the analytes are converted into their pentafluoropropionic acid amides. Separation and quantitative analysis is carried out by capillary gas chromatography and mass-selective detection in the single ion monitoring mode. The limits of detection were within the range from 0.05 μg/1 (4-aminobiphenyl, o-anisidine, 3,5-dichloroaniline) to 2 μg/1 urine (4-amino-2,6-dinitrotoluene). The relative standard deviation of the within-series imprecision (determined at spiked concentrations of 2.0 μg/1 and 10 μg/1) was between 2.9 and 13.6% depending on analyte and concentration. The relative recovery rates were in the range of 70-121%. The analytes that do not contain a nitro function showed better performance regarding the analytical reliability criteria. In order to determine the suitability of this new method for biological monitoring we analysed 20 12-h urine samples of persons without known exposure to aromatic amines, nitroaromatics or precursors in a pilot study. In these samples various aromatic amines could be clearly identified. The general population renally excretes aniline (median: 3.5 μg/1; 95th percentile: 7.9 μg/1), o-(0.12 μg/1; 2.7 μg/1), m- (0.17 μg/1; 2.2 μg/1) and p-toluidine (0.11 μg/1; 0.43 μg/1), and o-anisidine (0.22 μg/1; 0.68 μg/1). Additionally, we found that the persons investigated also excrete 3- (<0.05 μg/1; 0.55 μg/1) and 4-chloroaniline (0.11 μg/1; 0.57 μg/1) as well as 3,5-dichloroaniline (0.18 μg/1; 1.5 μg/1). 3,4-Dichloroaniline was found in some specimens (20%) in concentrations near the limit of detection (<0.05 μg/1; 0.12 μg/1). We did not detect α- or β-naphtylamine, 4-aminobiphenyl or metabolites of explosives in the samples.
机译:一种新开发的方法允许一次分析运行中同时定量测定人尿液中的各种芳香胺(或分别为芳香族硝基化合物的代谢物)。应用此方法可以测定苯胺,甲苯胺,4-异丙基苯胺,邻苯甲胺,3-和4-氯苯胺,4-溴苯胺,氨基硝基甲苯,氨基二硝基甲苯,3,5-和3,4-二氯苯胺,α-和β -萘胺和4-氨基二苯基。通过在pH 6.2-6.4处进行简单的液-液萃取从尿液基质中分离出来后,分析物被转化为五氟丙酸酰胺。分离和定量分析通过毛细管气相色谱法和单离子监测模式下的质量选择检测进行。检测限在0.05μg/ 1(4-氨基联苯,邻氨基苯甲酸酯,3,5-二氯苯胺)至2μg/ 1尿液(4-氨基-2,6-二硝基甲苯)的范围内。系列内不精密度的相对标准偏差(在2.0μg/ 1和10μg/ 1的加标浓度下确定)在2.9%和13.6%之间,具体取决于分析物和浓度。相对回收率在70-121%的范围内。就分析可靠性标准而言,不含硝基功能的分析物表现出更好的性能。为了确定这种新方法对生物监测的适用性,我们在一项试点研究中分析了20名12小时未曾暴露于芳香胺,硝基芳香烃或前体的人的尿液样本。在这些样品中,可以清楚地识别出各种芳香胺。一般人群肾排泄苯胺(中位数:3.5μg/ 1; 95%:7.9μg/ 1),o-(0.12μg/ 1; 2.7μg/ 1),m-(0.17μg/ 1; 2.2μg/ 1)对甲苯胺(0.11μg/ 1; 0.43μg/ 1)和邻茴香胺(0.22μg/ 1; 0.68μg/ 1)。此外,我们发现被调查者还排泄了3-(<0.05μg/ 1; 0.55μg/ 1)和4-氯苯胺(0.11μg/ 1; 0.57μg/ 1)以及3,5-二氯苯胺(0.18μg)。 /1;1.5μg/ 1)。在一些标本中发现3,4-二氯苯胺(20%)的浓度接近检出限(<0.05μg/ 1; 0.12μg/ 1)。我们没有在样品中检测到α-或β-萘胺,4-氨基联苯或炸药的代谢产物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号